The FDA is advising a warning be placed on flu drugs Tamiflu and Relenza due to psychiatriac events associated with the two drugs. Two years ago, the FDA could not make a direct link between the deaths of 12 Japanese children and Tamiflu but the federal agency did update Tamiflu’s label concerning supervision of patients exhibiting delirium or self-injury.